Cargando…

SARS-CoV-2 in hospital air as revealed by comprehensive respiratory viral panel sequencing

BACKGROUND: Nosocomially acquired severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection has become the most significant pandemic of our lifetime. Though its transmission was essentially attributed to droplets from an infected person, with recent advancements in knowledge, aeros...

Descripción completa

Detalles Bibliográficos
Autores principales: Habibi, Nazima, Uddin, Saif, Behbehani, Montaha, Abdul Razzack, Nasreem, Zakir, Farhana, Shajan, Anisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711137/
https://www.ncbi.nlm.nih.gov/pubmed/34977533
http://dx.doi.org/10.1016/j.infpip.2021.100199
_version_ 1784623311799451648
author Habibi, Nazima
Uddin, Saif
Behbehani, Montaha
Abdul Razzack, Nasreem
Zakir, Farhana
Shajan, Anisha
author_facet Habibi, Nazima
Uddin, Saif
Behbehani, Montaha
Abdul Razzack, Nasreem
Zakir, Farhana
Shajan, Anisha
author_sort Habibi, Nazima
collection PubMed
description BACKGROUND: Nosocomially acquired severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection has become the most significant pandemic of our lifetime. Though its transmission was essentially attributed to droplets from an infected person, with recent advancements in knowledge, aerosol transmission seems to be a viable pathway, as well. Because of the lower biological load in ambient aerosol, detection of SARS-CoV-2 is challenging. A few recent attempts of sampling large aerosol volumes and using next-generation sequencing (NGS) to detect the presence of SARS-CoV-2 in the air at very low levels gave positive results. These results suggest the potential of using this technique to detect the presence of SARS-CoV-2 and use it as an early warning signal for possible outbreak or recurrence of coronavirus disease 2019 (COVID-19). AIM: To assess efficacy of comprehensive respiratory viral panel (CRVP) sequencing and RT-PCR for low-level identification of SARS-CoV-2 and other respiratory viruses in indoor air. METHODS: A large volume of indoor aerosol samples from three major hospitals involved in COVID-19 care in Kuwait was collected. Viral RNA was isolated and subjected to comprehensive respiratory viral panel sequencing (CRVP) as per the standard protocol to detect the SARS-CoV-2 and other respiratory viruses in the hospital aerosol and monitor variations within the sequences. RT-PCR was also employed to estimate the viral load of SARS-CoV-2. FINDINGS: 13 of 15 (86.7%) samples exhibited SARS-CoV-2 with a relative abundance of 0.2–33.3%. The co-occurrence of human adenoviruses (type C1, C2, C5, C4), respiratory syncytial virus (RSV), influenza B, and non-SARS-CoV-229E were also recorded. Alignment of SARS-CoV-2 sequences against the reference strain of Wuhan China revealed variations in the form of single nucleotide polymorphisms (SNPs-17), insertions and deletions (indels-1). These variations were predicted to create missense (16), synonymous (15), frameshift (1) and stop-gained (1) mutations with a high (2), low (15), and moderate (16) impact. CONCLUSIONS: Our results suggest that using CRVP on a large volume aerosol sample was a valuable tool for detecting SARS-CoV-2 in indoor aerosols of health care settings. Owing to its higher sensitivity, it can be employed as a surveillance strategy in the post COVID times to act as an early warning system to possibly control future outbreaks.
format Online
Article
Text
id pubmed-8711137
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87111372021-12-28 SARS-CoV-2 in hospital air as revealed by comprehensive respiratory viral panel sequencing Habibi, Nazima Uddin, Saif Behbehani, Montaha Abdul Razzack, Nasreem Zakir, Farhana Shajan, Anisha Infect Prev Pract Original Research Article BACKGROUND: Nosocomially acquired severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection has become the most significant pandemic of our lifetime. Though its transmission was essentially attributed to droplets from an infected person, with recent advancements in knowledge, aerosol transmission seems to be a viable pathway, as well. Because of the lower biological load in ambient aerosol, detection of SARS-CoV-2 is challenging. A few recent attempts of sampling large aerosol volumes and using next-generation sequencing (NGS) to detect the presence of SARS-CoV-2 in the air at very low levels gave positive results. These results suggest the potential of using this technique to detect the presence of SARS-CoV-2 and use it as an early warning signal for possible outbreak or recurrence of coronavirus disease 2019 (COVID-19). AIM: To assess efficacy of comprehensive respiratory viral panel (CRVP) sequencing and RT-PCR for low-level identification of SARS-CoV-2 and other respiratory viruses in indoor air. METHODS: A large volume of indoor aerosol samples from three major hospitals involved in COVID-19 care in Kuwait was collected. Viral RNA was isolated and subjected to comprehensive respiratory viral panel sequencing (CRVP) as per the standard protocol to detect the SARS-CoV-2 and other respiratory viruses in the hospital aerosol and monitor variations within the sequences. RT-PCR was also employed to estimate the viral load of SARS-CoV-2. FINDINGS: 13 of 15 (86.7%) samples exhibited SARS-CoV-2 with a relative abundance of 0.2–33.3%. The co-occurrence of human adenoviruses (type C1, C2, C5, C4), respiratory syncytial virus (RSV), influenza B, and non-SARS-CoV-229E were also recorded. Alignment of SARS-CoV-2 sequences against the reference strain of Wuhan China revealed variations in the form of single nucleotide polymorphisms (SNPs-17), insertions and deletions (indels-1). These variations were predicted to create missense (16), synonymous (15), frameshift (1) and stop-gained (1) mutations with a high (2), low (15), and moderate (16) impact. CONCLUSIONS: Our results suggest that using CRVP on a large volume aerosol sample was a valuable tool for detecting SARS-CoV-2 in indoor aerosols of health care settings. Owing to its higher sensitivity, it can be employed as a surveillance strategy in the post COVID times to act as an early warning system to possibly control future outbreaks. Elsevier 2021-12-27 /pmc/articles/PMC8711137/ /pubmed/34977533 http://dx.doi.org/10.1016/j.infpip.2021.100199 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
Habibi, Nazima
Uddin, Saif
Behbehani, Montaha
Abdul Razzack, Nasreem
Zakir, Farhana
Shajan, Anisha
SARS-CoV-2 in hospital air as revealed by comprehensive respiratory viral panel sequencing
title SARS-CoV-2 in hospital air as revealed by comprehensive respiratory viral panel sequencing
title_full SARS-CoV-2 in hospital air as revealed by comprehensive respiratory viral panel sequencing
title_fullStr SARS-CoV-2 in hospital air as revealed by comprehensive respiratory viral panel sequencing
title_full_unstemmed SARS-CoV-2 in hospital air as revealed by comprehensive respiratory viral panel sequencing
title_short SARS-CoV-2 in hospital air as revealed by comprehensive respiratory viral panel sequencing
title_sort sars-cov-2 in hospital air as revealed by comprehensive respiratory viral panel sequencing
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711137/
https://www.ncbi.nlm.nih.gov/pubmed/34977533
http://dx.doi.org/10.1016/j.infpip.2021.100199
work_keys_str_mv AT habibinazima sarscov2inhospitalairasrevealedbycomprehensiverespiratoryviralpanelsequencing
AT uddinsaif sarscov2inhospitalairasrevealedbycomprehensiverespiratoryviralpanelsequencing
AT behbehanimontaha sarscov2inhospitalairasrevealedbycomprehensiverespiratoryviralpanelsequencing
AT abdulrazzacknasreem sarscov2inhospitalairasrevealedbycomprehensiverespiratoryviralpanelsequencing
AT zakirfarhana sarscov2inhospitalairasrevealedbycomprehensiverespiratoryviralpanelsequencing
AT shajananisha sarscov2inhospitalairasrevealedbycomprehensiverespiratoryviralpanelsequencing